Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.

Abstract:

BACKGROUND:Mesenchymal stromal cells (MSCs) have been largely investigated, in the past decade, as potential therapeutic strategies for various acute and chronic pathological conditions. MSCs isolated from different sources, such as bone marrow (BM), umbilical cord tissue (UCT) and adipose tissue (AT), share many biological features, although they may show some differences on cumulative yield, proliferative ability and differentiation potential. The standardization of MSCs growth and their functional amplification is a mandatory objective of cell therapies. The aim of this study was to evaluate the cumulative yield and the ex vivo amplification potential of MSCs obtained from various sources and different subjects, using defined culture conditions with a standardized platelet lysate (PL) as growth stimulus. METHODS:MSCs isolated from BM, UCT and AT and expanded in human PL were compared in terms of cumulative yield and growth potential per gram of starting tissue. MSCs morphology, phenotype, differentiation potential, and immunomodulatory properties were also investigated to evaluate their biological characteristics. RESULTS:The use of standardized PL-based culture conditions resulted in a very low variability of MSC growth. Our data showed that AT has the greater capacity to generate MSC per gram of initial tissue, compared to BM and UCT. However, UCT-MSCs replicated faster than AT-MSCs and BM-MSCs, revealing a greater proliferation capacity of this source irrespective of its lower MSC yield. All MSCs exhibited the typical MSC phenotype and the ability to differentiate into all mesodermal lineages, while BM-MSCs showed the most prominent immunosuppressive effect in vitro. CONCLUSIONS:The adoption of standardized culture conditions may help researchers and clinicians to reveal particular characteristics and inter-individual variability of MSCs sourced from different tissues. These data will be beneficial to set the standards for tissue collection and MSCs clinical-scale expansion both for cell banking and for cell-based therapy settings.

journal_name

Stem Cell Res Ther

authors

Fazzina R,Iudicone P,Fioravanti D,Bonanno G,Totta P,Zizzari IG,Pierelli L

doi

10.1186/s13287-016-0383-3

subject

Has Abstract

pub_date

2016-08-25 00:00:00

pages

122

issue

1

issn

1757-6512

pii

10.1186/s13287-016-0383-3

journal_volume

7

pub_type

杂志文章
  • Comparative analysis of mesenchymal stem cell and embryonic tendon progenitor cell response to embryonic tendon biochemical and mechanical factors.

    abstract:INTRODUCTION:Advances in tendon engineering with mesenchymal stem cells (MSCs) are hindered by a need for cues to direct tenogenesis, and markers to assess tenogenic state. We examined the effects of factors involved in embryonic tendon development on adult MSCs, and compared MSC responses to that of embryonic tendon p...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-015-0043-z

    authors: Brown JP,Galassi TV,Stoppato M,Schiele NR,Kuo CK

    更新日期:2015-05-09 00:00:00

  • Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study.

    abstract:BACKGROUND:Mesenchymal stromal/stem cells derived from human umbilical cord (UC-MSCs) uniquely combine properties of embryonic and postnatal MSCs and may be the most acceptable, safe, and effective source for allogeneic cell therapy e.g. for therapeutic angiogenesis. In this report we describe pro-angiogenic properties...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-016-0305-4

    authors: Arutyunyan I,Fatkhudinov T,Kananykhina E,Usman N,Elchaninov A,Makarov A,Bolshakova G,Goldshtein D,Sukhikh G

    更新日期:2016-03-22 00:00:00

  • Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload.

    abstract:INTRODUCTION:Stem cell therapy has emerged as potential therapeutic strategy for damaged heart muscles. Umbilical cord blood (UCB) cells are the most prevalent stem cell source available, yet have not been fully tested in cardiac regeneration. Herein, studies were performed to evaluate the cardiovascular safety and ben...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-015-0044-y

    authors: Oommen S,Yamada S,Cantero Peral S,Campbell KA,Bruinsma ES,Terzic A,Nelson TJ

    更新日期:2015-03-26 00:00:00

  • Bone marrow-derived neural crest precursors improve nerve defect repair partially through secreted trophic factors.

    abstract:BACKGROUND:Emerging evidence suggests that neural crest-derived cells (NCCs) present important functions in peripheral nerve regeneration to correct the insufficiency of autogenous Schwann cells. Postmigratory NCCs have been successfully isolated from adult rat bone marrow in our previous work. In this study, we aim to...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-019-1517-1

    authors: Shi H,Li X,Yang J,Zhao Y,Xue C,Wang Y,He Q,Shen M,Zhang Q,Yang Y,Ding F

    更新日期:2019-12-18 00:00:00

  • Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.

    abstract:INTRODUCTION:Nervous system injuries comprise a diverse group of disorders that include traumatic brain injury (TBI). The potential of mesenchymal stem cells (MSCs) to differentiate into neural cell types has aroused hope for the possible development of autologous therapies for central nervous system injury. METHODS:I...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/scrt151

    authors: Nichols JE,Niles JA,DeWitt D,Prough D,Parsley M,Vega S,Cantu A,Lee E,Cortiella J

    更新日期:2013-01-06 00:00:00

  • Progress on stem cell research towards the treatment of Parkinson's disease.

    abstract::Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive accumulation of Lewy body inclusions along with selective destruction of dopaminergic (DA) neurons in the nigrostriatal tract of the brain. Genetic studies have revealed much about the pathophysiology of PD, enabling the identifi...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/scrt102

    authors: Gibson SA,Gao GD,McDonagh K,Shen S

    更新日期:2012-04-03 00:00:00

  • Prognosis after autologous peripheral blood stem cell transplantation for osteonecrosis of the femoral head in the pre-collapse stage: a retrospective cohort study.

    abstract:OBJECTIVES:Autologous peripheral blood stem cell (auto-PBSC) transplantation is an effective therapeutic for the osteonecrosis of the femoral head (ONFH) but without prognosis estimation. This study mainly aimed to (1) determine whether auto-PBSC transplantation is a promising option, (2) assess the risk of hip-preserv...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-01595-w

    authors: Pan J,Ding Q,Lv S,Xia B,Jin H,Chen D,Xiao L,Tong P

    更新日期:2020-02-26 00:00:00

  • Angiopoietin-1 receptor Tie2 distinguishes multipotent differentiation capability in bovine coccygeal nucleus pulposus cells.

    abstract:BACKGROUND:The intervertebral disc (IVD) has limited self-healing potential and disc repair strategies require an appropriate cell source such as progenitor cells that could regenerate the damaged cells and tissues. The objective of this study was to identify nucleus pulposus-derived progenitor cells (NPPC) and examine...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-016-0337-9

    authors: Tekari A,Chan SCW,Sakai D,Grad S,Gantenbein B

    更新日期:2016-05-23 00:00:00

  • Dormancy in the stem cell niche.

    abstract::Tissues characterized by constant turnover contain post-mitotic, terminally differentiated cells originating from highly proliferative progenitors, which in turn derive from a relatively small population of stem cells. At the population level, self-renewal and differentiation are the possible outcomes of stem cell pro...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/scrt101

    authors: Sottocornola R,Lo Celso C

    更新日期:2012-03-19 00:00:00

  • Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial.

    abstract:BACKGROUND:Autologous grafting, despite some disadvantages, is still considered the gold standard for reconstruction of maxillofacial bone defects. The aim of this study was to evaluate bone regeneration using bone marrow-derived mesenchymal stromal cells (MSCs) in a clinical trial, a less invasive approach than autolo...

    journal_title:Stem cell research & therapy

    pub_type: 临床试验,杂志文章

    doi:10.1186/s13287-018-0951-9

    authors: Gjerde C,Mustafa K,Hellem S,Rojewski M,Gjengedal H,Yassin MA,Feng X,Skaale S,Berge T,Rosen A,Shi XQ,Ahmed AB,Gjertsen BT,Schrezenmeier H,Layrolle P

    更新日期:2018-08-09 00:00:00

  • High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA.

    abstract:INTRODUCTION:A feature which makes stem cells promising candidates for cell therapy is their ability to migrate effectively into damaged or diseased tissues. Recent reports demonstrated the increased motility of human mesenchymal stem cells (hMSC) grown under hypoxic conditions compared to normoxic cells. However, the ...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/scrt153

    authors: Vertelov G,Kharazi L,Muralidhar MG,Sanati G,Tankovich T,Kharazi A

    更新日期:2013-01-07 00:00:00

  • Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight.

    abstract:BACKGROUND:Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells currently tested for multiple therapeutic purposes. Their potential to home into tumors, to secrete trophic/vasculogenic factors, and to suppress immune response raises questions regarding their biosafety. Our aim was to evaluate wheth...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-018-0878-1

    authors: Bruna F,Plaza A,Arango M,Espinoza I,Conget P

    更新日期:2018-05-11 00:00:00

  • TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.

    abstract:BACKGROUND:Patients suffering from osteoporosis show an increased number of adipocytes in their bone marrow, concomitant with a reduction in the pool of human mesenchymal stem cells (hMSCs) that are able to differentiate into osteoblasts, thus leading to suppressed osteogenesis. METHODS:In order to be able to interfer...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-016-0375-3

    authors: van Zoelen EJ,Duarte I,Hendriks JM,van der Woning SP

    更新日期:2016-08-26 00:00:00

  • Activin A expression regulates multipotency of mesenchymal progenitor cells.

    abstract:INTRODUCTION:Bone marrow (BM) stroma currently represents the most common and investigated source of mesenchymal progenitor cells (MPCs); however, comparable adult progenitor or stem cells have also been isolated from a wide variety of tissues. This study aims to assess the functional similarities of MPCs from differen...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/scrt11

    authors: Djouad F,Jackson WM,Bobick BE,Janjanin S,Song Y,Huang GT,Tuan RS

    更新日期:2010-05-04 00:00:00

  • MagT1 regulated the odontogenic differentiation of BMMSCs induced byTGC-CM via ERK signaling pathway.

    abstract:BACKGROUND:Bone marrow mesenchymal stem cells (BMMSCs) are suitable cell sources for dental pulp regeneration, but the mechanism of BMMSCs differentiation into odontogenic lineage remains unknown. The aim of the present study was to reveal the role of magnesium transporter protein 1 (MagT1) and MAPK pathways in the odo...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-019-1148-6

    authors: Zheng JM,Kong YY,Li YY,Zhang W

    更新日期:2019-01-31 00:00:00

  • Human umbilical cord stem cell conditioned medium versus serum-free culture medium in the treatment of cryopreserved human ovarian tissues in in-vitro culture: a randomized controlled trial.

    abstract:BACKGROUND:To reduce young female fertility loss, the in-vitro culture of cryopreserved ovarian cortical tissues (OCTs) is considered an effective approach without delaying treatment and undergoing stimulation medicine. However, ischemic damage and follicular loss during the in-vitro culture of OCTs are major technical...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s13287-017-0604-4

    authors: Jia Y,Shi X,Xie Y,Xie X,Wang Y,Li S

    更新日期:2017-06-24 00:00:00

  • Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury.

    abstract:INTRODUCTION:Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (C...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/scrt489

    authors: Xing L,Cui R,Peng L,Ma J,Chen X,Xie RJ,Li B

    更新日期:2014-08-21 00:00:00

  • Substance P and patterned silk biomaterial stimulate periodontal ligament stem cells to form corneal stroma in a bioengineered three-dimensional model.

    abstract:BACKGROUND:We aimed to generate a bioengineered multi-lamellar human corneal stroma tissue in vitro by differentiating periodontal ligament stem cells (PDLSCs) towards keratocytes on an aligned silk membrane. METHODS:Human PDLSCs were isolated and identified. The neuropeptide substance P (SP) was added in keratocyte d...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-017-0715-y

    authors: Chen J,Zhang W,Kelk P,Backman LJ,Danielson P

    更新日期:2017-11-13 00:00:00

  • Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

    abstract:BACKGROUND:Mesenchymal stromal cells (MSCs) are considered to have a modest benefit on left ventricular ejection fraction (LVEF) in patients with acute myocardial infarction (AMI). However, the optimal injection timing and dose needed to induce beneficial cardiac effects are unknown. The purpose of this meta-analysis w...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13287-016-0450-9

    authors: Wang Z,Wang L,Su X,Pu J,Jiang M,He B

    更新日期:2017-01-28 00:00:00

  • Paracrine stimulation of perinatal lung functional and structural maturation by mesenchymal stem cells.

    abstract:BACKGROUND:Mesenchymal stem cells (MSCs) were shown to harbor therapeutic potential in models of respiratory diseases, such as bronchopulmonary dysplasia (BPD), the most common sequel of preterm birth. In these studies, cells or animals were challenged with hyperoxia or other injury-inducing agents. However, little is ...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-02028-4

    authors: Obendorf J,Fabian C,Thome UH,Laube M

    更新日期:2020-12-09 00:00:00

  • Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.

    abstract:INTRODUCTION:Idiopathic pulmonary fibrosis is a progressive diffuse parenchymal lung disorder of unknown etiology. Mesenchymal stem cell (MSC)-based therapy is a novel approach with great therapeutic potential for the treatment of lung diseases. Despite demonstration of MSC grafting, the populations of engrafted MSCs h...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-015-0081-6

    authors: Lan YW,Choo KB,Chen CM,Hung TH,Chen YB,Hsieh CH,Kuo HP,Chong KY

    更新日期:2015-05-20 00:00:00

  • Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.

    abstract:INTRODUCTION:Fetal bovine serum (FBS) is an animal product used as a medium supplement. The animal origin of FBS is a concern if cultured stem cells are to be utilized for human cell therapy. Therefore, a substitute for FBS is desirable. In this study, an industrial, xeno-free, pharmaceutical-grade supplement for cell ...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-015-0016-2

    authors: Díez JM,Bauman E,Gajardo R,Jorquera JI

    更新日期:2015-03-13 00:00:00

  • Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation.

    abstract::On 23 May 2013, the Italian health minister decided to endorse a law regarding controversial stem cell-based therapies in 32 young terminally ill patients, shocking many scientists. According to the international scientific community, these therapies could be dangerous because they were not rigorously tested in humans...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/scrt333

    authors: Frati P,Frati G,Gulino M,Montanari Vergallo G,Di Luca A,Fineschi V

    更新日期:2013-10-11 00:00:00

  • Insulin-like growth factor-II overexpression accelerates parthenogenetic stem cell differentiation into cardiomyocytes and improves cardiac function after acute myocardial infarction in mice.

    abstract:BACKGROUND:Parthenogenetic stem cells (PSCs) are a promising source of regenerated cardiomyocytes; however, their application may be limited without a paternal genome. Insulin-like growth factor-II (IGF-II), a paternally expressed growth hormone, is critical in embryonic differentiation. This study investigated whether...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-1575-4

    authors: Sui Y,Zhang W,Tang T,Gao L,Cao T,Zhu H,You Q,Yu B,Yang T

    更新日期:2020-02-26 00:00:00

  • The march of pluripotent stem cells in cardiovascular regenerative medicine.

    abstract::Cardiovascular disease (CVD) continues to be the leading cause of global morbidity and mortality. Heart failure remains a major contributor to this mortality. Despite major therapeutic advances over the past decades, a better understanding of molecular and cellular mechanisms of CVD as well as improved therapeutic str...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s13287-018-0947-5

    authors: Abou-Saleh H,Zouein FA,El-Yazbi A,Sanoudou D,Raynaud C,Rao C,Pintus G,Dehaini H,Eid AH

    更新日期:2018-07-27 00:00:00

  • Among mesenchymal stem cells: for the best therapy after ischemic stroke.

    abstract::Owing to the several advantages that they have over other cells, mesenchymal stem cells are among the most promising tools in stem cell therapy after ischemic stroke. Mesenchymal stem cells can be obtained from various sources. Therefore, a wide range of careful comparative studies of these cells is required, from the...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/scrt157

    authors: Ikegame Y

    更新日期:2013-01-31 00:00:00

  • Efficacy of matrilin-3-primed adipose-derived mesenchymal stem cell spheroids in a rabbit model of disc degeneration.

    abstract:BACKGROUND:Chronic low back pain is a prevalent disability, often caused by intervertebral disc (IVD) degeneration. Mesenchymal stem cell (MSC) therapy could be a safe and feasible option for repairing the degenerated disc. However, for successful translation to the clinic, various challenges need to be overcome includ...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-01862-w

    authors: Muttigi MS,Kim BJ,Kumar H,Park S,Choi UY,Han I,Park H,Lee SH

    更新日期:2020-08-24 00:00:00

  • miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells.

    abstract:BACKGROUND:miRNA expression profiles in ectopic endometrium (EC) serving as pathophysiologic genetic fingerprints contribute to determining endometriosis progression; however, the underlying molecular mechanisms remain unknown. METHODS:miRNA microarray analysis was used to determine the expression profiling of EC fres...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-019-1388-5

    authors: Zhou CF,Liu MJ,Wang W,Wu S,Huang YX,Chen GB,Liu LM,Peng DX,Wang XF,Cai XZ,Li XX,Feng WQ,Ma Y

    更新日期:2019-09-23 00:00:00

  • Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA.

    abstract:BACKGROUND:Osteoarthritis (OA) is a major cause of limb dysfunction, and distraction arthroplasty which generates intermittent hydrostatic pressure (IHP) is an effective approach for OA treatment. However, the result was not always satisfactory and the reasons remained unresolved. Because aging is recognized as an impo...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-01708-5

    authors: Dai H,Chen R,Gui C,Tao T,Ge Y,Zhao X,Qin R,Yao W,Gu S,Jiang Y,Gui J

    更新日期:2020-05-25 00:00:00

  • Tetramethylpyrazine enhanced the therapeutic effects of human umbilical cord mesenchymal stem cells in experimental autoimmune encephalomyelitis mice through Nrf2/HO-1 signaling pathway.

    abstract:INTRODUCTION:The therapeutic effects of mesenchymal stem cells (MSCs) have been limited by their apoptosis induced by oxidative stress after delivery into the injured sites. Therefore, strategies designed to improve the MSC therapeutic efficacy need to be explored. Tetramethylpyrazine (TMP) can promote the proliferatio...

    journal_title:Stem cell research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13287-020-01700-z

    authors: Zhang L,Wang X,Lu X,Ma Y,Xin X,Xu X,Wang S,Hou Y

    更新日期:2020-05-19 00:00:00